https://www.selleckchem.com/pr....oducts/lenalidomide-
Activities to control human African trypanosomiasis (HAT) in Guinea were severely hampered by the Ebola epidemic that hit this country between 2014 and 2016. Active screening was completely interrupted and passive screening could only be maintained in a few health facilities. At the end of the epidemic, medical interventions were progressively intensified to mitigate the risk of HAT resurgence and progress towards disease elimination. A retrospective analysis was performed to evaluate the medical activities that were implemen
Curtir
Comentario
Compartilhar
